Department of Ophthalmology, College of Medicine, University of Ibadan, Nigeria.
Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queens University, Belfast, United Kingdom.
J Glaucoma. 2023 Oct 1;32(10):815-819. doi: 10.1097/IJG.0000000000002273. Epub 2023 Jul 21.
Physicians were most likely to recommend primary medical therapy upon diagnosis of glaucoma. Laser therapy was underutilized where they were available. Physicians were more likely to recommend surgery in severe glaucoma, laser therapy in mild glaucoma, while recommendation of medical therapy did not depend on glaucoma severity.
To characterize treatment patterns for newly diagnosed glaucoma in sub-Saharan Africa (SSA).
This was a multicenter cross-sectional study of adults newly diagnosed with glaucoma at 27 eye care centers in 10 African countries. In addition to demographic and clinical data, physician treatment recommendations (medication, laser, surgery, or no treatment) were recorded. Statistical analyses were performed using STATA version 14.0.
Data from 1201 patients were analyzed. Physicians were most likely to recommend primary medical therapy upon diagnosis of glaucoma (69.4%), with laser (13.2%), surgery (14.9%), and no treatment (2.5%) recommended to the remaining patients. All sites had medical therapy available and most (25/27, 92.6%) could provide surgical treatment; only 16/27 (59.3%) sites offered laser, and at these sites, 30.8% of eyes were recommended to undergo primary laser procedures. As glaucoma severity increased, the laser was recommended less, surgery more, and medications unchanged. Patient acceptance of medical therapy was 99.1%, laser 88.3%, and surgery 69.3%.
Medical therapy for first-line glaucoma management is preferred by most physicians in SSA (69%). Laser therapy may be underutilized at centers where it is available. These findings underscore the need for comparative studies of glaucoma treatments in SSA to inform the development of evidence-based treatment guidelines and of programs to reduce glaucoma blindness in SSA. Strategic approaches to glaucoma therapy in SSA must address the question of whether medical therapy is the most optimal first-line approach in this setting.
在诊断青光眼后,医生最有可能推荐初级医疗疗法。在有激光疗法的地方,该疗法的利用率较低。在严重青光眼的情况下,医生更有可能推荐手术治疗,在轻度青光眼的情况下,更有可能推荐激光疗法,而对医疗疗法的推荐则不依赖于青光眼的严重程度。
描述撒哈拉以南非洲(SSA)新诊断为青光眼的治疗模式。
这是一项多中心、横断面研究,纳入了在 10 个非洲国家的 27 个眼科中心新诊断为青光眼的成年患者。除了人口统计学和临床数据外,还记录了医生的治疗建议(药物、激光、手术或不治疗)。使用 STATA 版本 14.0 进行统计分析。
分析了 1201 名患者的数据。医生最有可能在诊断青光眼后推荐初级医疗疗法(69.4%),其余患者推荐激光(13.2%)、手术(14.9%)和不治疗(2.5%)。所有地点均提供药物治疗,且大多数(25/27,92.6%)可提供手术治疗;仅有 27 个地点中的 16 个(59.3%)可提供激光治疗,且在这些地点中,30.8%的患者建议进行主要的激光治疗。随着青光眼严重程度的增加,激光治疗的推荐减少,手术治疗的推荐增加,药物治疗不变。对药物治疗的接受率为 99.1%,激光治疗为 88.3%,手术治疗为 69.3%。
在 SSA,大多数医生首选药物治疗作为一线青光眼治疗方法(69%)。在有激光疗法的中心,该疗法的利用率可能较低。这些发现突显了在 SSA 开展比较青光眼治疗研究的必要性,以制定基于证据的治疗指南,并开展减少 SSA 青光眼致盲的项目。在 SSA,治疗青光眼的战略方法必须解决药物治疗是否是该环境下最佳一线治疗方法的问题。